Neurologic

Anti-Clotting Treatment Not Recommended for All Stroke Patients

Published in Blood Weekly, October 23rd, 1995

Stroke patients do not benefit from intravenous thrombolysis (blood clot dissolvers), according to an article in the October 4, 1995, issue of the Journal of the American Medical Association (JAMA).

The research was presented at the American Medical Association's (AMA) 14th annual Science Reporters Conference.

Werner Hacke, M.D., from the University of Heidelberg, Germany, Markku Kaste, M.D., from the University of Helsinki, Finland, and colleagues found that recombinant tissue plasminogen activator (rt-PA), when administered within six hours of the onset of stroke symptoms, can improve some functional measures in stroke patients who have suffered...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1995-10-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry